ZFTA and sarcoma: C11orf95‐RELA has not been examined in primary ependymosarcomas; however, C11orf95‐RELA was detected both in primary anaplastic ependymoma and recurrent sarcoma in a patient; the latter developed after chemotherapy and radiation (32).